Probable Ponatinib-Induced Papilledema in a Patient with Acute Lymphocytic Leukemia

American journal of ophthalmology Case reports(2023)

引用 0|浏览9
暂无评分
摘要
•As reported with other tyrosine kinase inhibitors, ponatinib can induce papilledema.•Ponatinib induced papilledema can be treated with acetazolamide.•Visual disturbances during leukemia treatment should receive ophthalmic work up.•Patients taking ponatinib should consider periodic eye exams during treatment.
更多
查看译文
关键词
Papilledema,Ponatinib,Intracranial hypertension,Tyrosine kinase inhibitor,Acute lymphocytic leukemia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要